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 hen administering a drug to a show  
 animal, the owner must take the usual 
care to be certain the proper dosage is given and 
that the drug is administered properly. But there 
is another concern—the requirement that market 
show animals have no detectable levels of drugs in 
their urine when tested at a show. While the prod-
uct label specifies a drug’s withdrawal time, or the 
time it takes a drug in the animal’s tissue to reach a 
safe level for human consumption, the withdrawal 
time may be less than the time required for the 
urine to test negative. 
When determining withdrawal times, the Food 
and Drug Administration Center for Veterinary 
Medicine (FDA-CVM) evaluates information 
from healthy animals. In an unhealthy animal, the 
time it takes a drug to reach safe levels in tissues, 
and to disappear from urine, can be longer than in 
a healthy animal. 
One class of drugs, the sulfonamides, are of 
special concern when used in show market animals 
because, even though they may be administered 
correctly and the proper withdrawal times ob-
served, residues could remain in the urine. This can 
happen if the owner fails to give the animal ade-
quate amounts of water, without which there may 
be crystallization in the kidneys. This lengthens the 
time the drug will be detectable in the urine. It can 
also happen if the animal continues to be exposed 
to the drug through the environment, even after 
the drug is no longer being administered. For ex-
ample, the soil may contain sulfonamide excreted 
in urine and manure, or medicated drinking water 
may spill and accidentally contaminate the soil. If 
an animal ingests contaminated soil while grazing 
or feeding, its exposure to the drug continues.
Drug Information
Sulfonamides are organic sulfur compounds 
that contain the radical SO2NH2. They are used as 
antibiotics to treat bacterial infections in humans 
and animals. Sulfonamides work by interfering 
with a bacterium’s production of folic acid, which 
the bacterial cell needs for energy and reproduc-
tion. Sulfonamides have a limited effect on animal 
cells, which do not synthesize their own folic acid. 
Whether administered in feed, in water, by injec-
tion, or by mouth, sulfonamides are distributed 
throughout the body and into the soft tissues, 
including the cerebrospinal fluid and joints, and 
are excreted in the urine. 
In animals, sulfonamides are used to treat 
conditions such as bacterial pneumonia, bacterial 
scours, coccidiosis, foot rot, calf diphtheria, acute 
mastitis and acute metritis. 
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Sulfonamides are approved for a variety of ani-
mal species in a number of different forms. They 
are used to treat beef cattle, non-lactating dairy 
cattle, swine, chickens, carp, ewes, dogs, quail, 
horses and turkeys. Sulfonamides are adminis-
tered intravenously, subcutaneously or orally. The 
oral forms are tablets or boluses administered by 
hand, or powders or liquids administered in drink-
ing water. The dosages, durations and withdrawal 
times vary by species and product. Before admin-
istering a sulfonamide, or any drug, read the label. 
Table 1 lists examples of common sulfonamides 
approved in the U.S. for food-producing animals.
Regulatory Issues
When used improperly, sulfonamides can be 
hazardous to human health. While many steps 
have been taken to ensure that the food supply is 
safe from toxic levels of sulfonamides, they remain 
a top concern. The FDA-CVM has established a 
tolerance of 0.1 part per million for negligible resi-
dues of sulfamethazine in the uncooked, edible 
tissues of chickens, turkeys, cattle and swine.  
The FDA-CVM is responsible for determining 
the marketing status (Prescription-Rx, Over-the-
Counter-OTC, or Veterinary Feed Directive-
VFD) of animal drug products. The agency bases 
this determination on whether or not it is possible 
to prepare “adequate directions for use” under 
which a layperson can use a drug safely and effec-
tively. A prescription animal drug is one the FDA-
CVM has determined laypeople can not use safely 
and effectively without the guidance of a licensed 
veterinarian because of
n	 the drug’s toxicity or other potential for 
harmful effects,
n	 the method of its use, or 
n	 the collateral measures necessary for its use.
Some sulfonamides are prescription animal 
drugs, while others are labeled for over-the-coun-
ter use.
Drugs in Market Show Animals
While drugs intended for medical purposes 
(such as antibiotics) and drugs used to enhance 
production (such as growth hormones) are ap-
proved for use in market show animals, some 
shows may not permit some medical drugs that are 
used as performance enhancers. Glucocorticoids 
such as dexamethasone may fall into this category. 
Other drugs that are not approved in market show 
animals include tranquilizers, local and systemic 
anesthetics, diuretics, caffeine, alcohol, and any 
other drug that is not medically indicated.
Table 1
Trade Name Species Ingredient Route of 
Administration
Drug Form
Agribon Soluble Powder 
Albon
Cattle, chickens, turkeys Sulfadimethoxine Oral Powder
Aureomycin Sulmet Soluble 
Powder
Swine Sulfamethazine
chlorotetracycline 
bisulfate
Oral Powder
S.E.Z. Drinking Water 6.25% Cattle, swine Sulfaethoxypyridazine Oral Liquid
S.E.Z. Intravenous Solution Cattle Sulfaethoxypyridazine Intravenous Liquid
S.E.Z. Oblets 15 G Cattle Sulfaethoxypyridazine Oral Tablet
Sodium Sulfachloropyrazine 
Solution
Chickens Sodium and 
sulfachloropyrazine 
monohydrate
Oral Liquid
Sustain III Cattle Sulfamethazine Oral Sustained release bolus
It is the responsibility of anyone who adminis-
ters drugs to show animals to do so in accordance 
with the regulations on the drug’s label. That 
means giving a drug to an approved animal spe-
cies, for an approved indication, by an approved 
route of administration, and at an approved dos-
age as well as observing the approved withdrawal 
times, unless specifically directed by a veterinarian 
within a valid veterinarian-client-patient relation-
ship. 
Owners of show animals would be wise to 
remember that some drugs, such as sulfonamides, 
may be detectable in the urine longer than the 
withdrawal time on the product label. It is prudent 
to allow extra time after drugs are used to avoid a 
positive test result.
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